FDA to Remove Black Box Warning on Menopause Treatments

The lengthy “black box” warning on menopause treatments is finally undergoing some changes.

Research published in 2002 showed that menopause hormone therapy carried a risk of cancer and other serious conditions – understandably scaring off many patients and even discouraging doctors from discussing it.

But new research in the years since has painted a diffrent picture, and the FDA is finally responding. They’re removing the strongest type of warning on many pills, patches, injections, and creams used for menopause and perimenopause symptoms.

This morning,the Department of Health and Human Services announced it will be removing “misleading FDA warnings on hormone replacement therapy.”

“Today, we are standing up for every woman who has symptoms of menopause and is looking to know her options and receive possibly life-changing treatment,” said Secretary Robert F. Kennedy.

“For more than two decades,bad science and bureaucratic inertia have resulted in women and physicians having an incomplete view of HRT. We are returning to evidence-based medicine and giving women control over their health again.”

Medical professionals are supporting this move.

“The black box warning has been enough of a deterrent to prevent doctors from offering it to their patients,” Dr. Nora Lansen, a board and Menopause Society-certified family physician and Elektra’s Chief Medical Officer, told The Post.

“Clinicians who provide menopause care have known for a long time that the black